Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 SEK | -96.26% | -.--% | -22.82% |
Sales 2021 | 844K 77.44K | Sales 2022 | 1.14M 105K | Capitalization | 595M 54.61M |
---|---|---|---|---|---|
Net income 2021 | -156M -14.31M | Net income 2022 | -168M -15.42M | EV / Sales 2021 | 1,710 x |
Net cash position 2021 | 254M 23.32M | Net cash position 2022 | 68.47M 6.28M | EV / Sales 2022 | 460 x |
P/E ratio 2021 |
-10.9
x | P/E ratio 2022 |
-3.54
x | Employees | 11 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 75.52% |
Latest transcript on Immunovia AB
1 day | -96.26% | ||
3 months | -27.79% | ||
6 months | +41.56% | ||
Current year | -22.82% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 22-03-31 | |
Karl Stone
COO | Chief Operating Officer | 61 | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 16-12-08 | |
Peter Andersen
CHM | Chairman | 67 | 19-12-31 |
Michael Löfman
BRD | Director/Board Member | - | 23-05-21 |
1st Jan change | Capi. | |
---|---|---|
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-7.14% | 716M | |
-18.10% | 682M |
- Stock Market
- Equities
- IMMNOV Stock
- 0G8X Stock